12 Publikationen
-
2021 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2946327Anselmi, M., Borbély, A. N., Figueras Agustí, E., Michalek, C., Kemker, I., Gentilucci, L., and Sewald, N. (2021). Linker Hydrophilicity Modulates the Anticancer Activity of RGD-Cryptophycin Conjugates. Chemistry - A European Journal 27, 1015-1022.PUB | PDF | DOI | WoS | PubMed | Europe PMC
-
2020 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2940382Borbély, A. N., Thoreau, F., Figueras Agustí, E., Kadri, M., Coll, J. - L., Boturyn, D., and Sewald, N. (2020). Synthesis and Biological Characterization of Monomeric and Tetrameric RGD-Cryptophycin Conjugates. Chemistry - A European Journal 26, 2602-2605.PUB | PDF | DOI | WoS | PubMed | Europe PMC
-
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2936495Borbély, A. N., Figueras Agustí, E., Martins, A., Bodero, L., Raposo Moreira Dias, A., Lopez Rivas, P., Pina, A., Arosio, D., Gallinari, P., Frese, M., et al. (2019). Conjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug Delivery. ChemistryOpen 8, 737-742.PUB | PDF | DOI | WoS | PubMed | Europe PMC
-
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2934762Borbély, A. N., Figueras Agustí, E., Martins, A., Esposito, S., Auciello, G., Monteagudo, E., Di Marco, A., Summa, V., Cordella, P., Perego, R., et al. (2019). Synthesis and Biological Evaluation of RGD–Cryptophycin Conjugates for Targeted Drug Delivery. Pharmaceutics 11:151.PUB | PDF | DOI | WoS | PubMed | Europe PMC
-
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2935650Figueras Agustí, E., Martins, A., Borbély, A. N., Le Joncour, V., Cordella, P., Perego, R., Modena, D., Pagani, P., Esposito, S., Auciello, G., et al. (2019). Octreotide Conjugates for Tumor Targeting and Imaging. Pharmaceutics 11:220.PUB | PDF | DOI | WoS | PubMed | Europe PMC
-
-
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2920953Figueras Agustí, E., Borbély, A. N., Ismail, M., Frese, M., and Sewald, N. (2018). Novel unit B cryptophycin analogues as payloads for targeted therapy. Beilstein Journal of Organic Chemistry 14, 1281-1286.PUB | DOI | WoS | PubMed | Europe PMC
-
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2932984Cazzamalli, S., Figueras Agustí, E., Petho, L., Borbély, A. N., Steinkuhler, C., Neri, D., and Sewald, N. (2018). In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas. ACS Omega 3, 14726-14731.PUB | PDF | DOI | WoS | PubMed | Europe PMC
-
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2944897Cazzamalli, S., Figueras Agustí, E., Pethő, L., Borbély, A. N., Steinkühler, C., Neri, D., and Sewald, N. (2018). Correction: In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma. ACS Omega 3, 16743-16743.PUB | DOI | WoS | PubMed | Europe PMC
-
2018 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2931993Borbély, A. N., Figueras Agustí, E., Martins, A., Gallinari, P., Esposito, S., Auciello, G., Modena, D., Frese, M., Steinkuhler, C., and Sewald, N. (2018). “Novel Cryptophycin-based Conjugates for Tumor Targeting” in JOURNAL OF PEPTIDE SCIENCE, vol. 24, (Hoboken: Wiley), S59.PUB | WoS
-
2018 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2931996Figueras Agustí, E., Martins, A., Borbély, A. N., Gallinari, P., Esposito, S., Auciello, G., Modena, D., Pagani, P., Cordella, P., Perego, R., et al. (2018). “Tumor Targeting of Cryptophycin based Conjugates Using Octreotide as Delivery Vehicle” in JOURNAL OF PEPTIDE SCIENCE, vol. 24, (Hoboken: Wiley), S166.PUB | WoS
-